STAT3 inhibition experiments show immune cell specific effects, as demonstrated in the Mx1-cre-mediated STAT3 deletion model, in which antigen presentation by dendritic cells was enhanced to promote anti-tumor T cell responses [100]. The gene discussed is STAT3; the disease is neoplasm.